http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103079545-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dd3744903eb834766ef49252e1185c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
filingDate 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_def4e57076ea472e4ede854413ca0d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c21f67c8db1f2f1ddcae034c1c726c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca125f5f1156c82002fa899ed9c8932e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79790a7dcccf343bbbd1fef7c95a9331
publicationDate 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103079545-A
titleOfInvention Stabilization of sulforaphane
abstract Stable galenic compositions of compounds of the general formula (I) in which R and R independently of each other represent an alkyl, aryl, arylalkyl group, It is optionally substituted by one or more linear or branched, optionally cyclic groups optionally carrying one or more heteroatoms, Said composition comprises: said compound of formula (I), at least one cosmetically and pharmaceutically acceptable anhydrous esters, the main chain and/or optionally the branches of which have no free and/or reactive groups or functional groups, in an amount of 0.1% to 99.9% by weight relative to the total weight of the composition, and optionally Preferably, at least one cosmetically and pharmaceutically acceptable excipient is used to make up 100% of the total weight of the composition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107739324-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104720072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021115100-A1
priorityDate 2010-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101120948-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5411986-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008176942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2163238-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0215722-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2804318-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88556761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5368086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426082127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465632817

Total number of triples: 36.